Access Support for Orphan Drugs and Rare Disease Medicines in Kenya
Bioniche Limited supports patients, caregivers, healthcare providers and hospitals with access to orphan drugs and rare disease medicines that may not be routinely available in Kenya. Through our structured access model, we help coordinate product availability, prescription review, documentation, sourcing and regulatory support for prescribed specialty medicines.
Our goal is to improve access to life-changing therapies while ensuring every request follows the appropriate quality, regulatory and patient safety requirements.
What Are Orphan Drugs?
Orphan drugs are medicines developed to diagnose, prevent or treat rare diseases that affect a relatively small number of patients. Because these conditions are uncommon, the medicines required may not always be commercially available or routinely stocked in local healthcare facilities.
Bioniche Limited works with healthcare providers and trusted supply partners to support access to prescribed orphan medicines through a responsible and compliant process.
Conditions That May Require Orphan Medicines
Orphan drugs may be prescribed for patients living with rare or complex conditions, including:
- Rare genetic disorders
- Rare cancers
- Metabolic disorders
- Blood disorders
- Autoimmune diseases
- Neurological disorders
- Immunological conditions
- Other uncommon or life-threatening diseases
Every request is assessed individually based on the patient’s prescription, clinical requirements and product availability.
Our Orphan Drug Access Services
Bioniche Limited provides support with:
- Orphan drug availability enquiries
- Rare disease medicine sourcing
- Named Patient Programme requests
- Prescription verification
- Product quotations
- Special import support where applicable
- Hospital and institutional supply
- Regulatory documentation guidance
- Delivery coordination and follow-up
Availability depends on manufacturer supply, regulatory requirements and successful completion of the required documentation.